Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.084 | 0.005 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.007 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.009 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |